257 related articles for article (PubMed ID: 31705947)
1. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.
Leong JY; Herrera-Caceres JO; Goldberg H; Tham E; Teplitsky S; Gomella LG; Trabulsi EJ; Lallas CD; Fleshner NE; Tilki D; Chandrasekar T
Urology; 2020 Mar; 137():102-107. PubMed ID: 31705947
[TBL] [Abstract][Full Text] [Related]
2. Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.
Weaver JK; Kim EH; Vetter JM; Shetty A; Grubb RL; Strope SA; Andriole GL
Urology; 2018 Mar; 113():119-128. PubMed ID: 29217354
[TBL] [Abstract][Full Text] [Related]
3. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
4. Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario.
Leong JY; Herrera-Caceres JO; Goldberg H; Tham E; Teplitsky S; Gomella LG; Fleshner NE; Lallas CD; Trabulsi EJ; Chandrasekar T
Ther Adv Urol; 2019; 11():1756287219882809. PubMed ID: 31662795
[TBL] [Abstract][Full Text] [Related]
5. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
[TBL] [Abstract][Full Text] [Related]
7. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
8. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
[TBL] [Abstract][Full Text] [Related]
9. Do prostate cancer nomograms give accurate information when applied to European patients?
Turo R; Forster JA; West RM; Prescott S; Paul AB; Cross WR
Scand J Urol; 2015 Feb; 49(1):16-24. PubMed ID: 24882277
[TBL] [Abstract][Full Text] [Related]
10. Grade Group Underestimation in Prostate Biopsy: Predictive Factors and Outcomes in Candidates for Active Surveillance.
Audenet F; Rozet F; Resche-Rigon M; Bernard R; Ingels A; Prapotnich D; Sanchez-Salas R; Galiano M; Barret E; Cathelineau X
Clin Genitourin Cancer; 2017 Dec; 15(6):e907-e913. PubMed ID: 28522288
[TBL] [Abstract][Full Text] [Related]
11. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
13. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.
Bandini M; Marchioni M; Pompe RS; Tian Z; Gandaglia G; Fossati N; Abdollah F; Graefen M; Montorsi F; Saad F; Shariat SF; Briganti A; Karakiewicz PI
BJU Int; 2018 Apr; 121(4):592-599. PubMed ID: 29124911
[TBL] [Abstract][Full Text] [Related]
14. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
[TBL] [Abstract][Full Text] [Related]
15. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
Diolombi ML; Epstein JI
BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
[TBL] [Abstract][Full Text] [Related]
16. One-Stop-Shop Whole-Body
Thalgott M; Düwel C; Rauscher I; Heck MM; Haller B; Gafita A; Gschwend JE; Schwaiger M; Maurer T; Eiber M
J Nucl Med; 2018 Dec; 59(12):1850-1856. PubMed ID: 29794224
[TBL] [Abstract][Full Text] [Related]
17. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer.
Nason GJ; O'Connor EM; MacMahon D; Moss B; Considine SW; Cahill A; O'Rourke C; O'Brien FM
Ir J Med Sci; 2018 Feb; 187(1):33-37. PubMed ID: 28478609
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy.
Glaser ZA; Gordetsky JB; Bae S; Nix JW; Porter KK; Rais-Bahrami S
Urol Oncol; 2019 Dec; 37(12):970-975. PubMed ID: 31495569
[TBL] [Abstract][Full Text] [Related]
20. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]